Frank Weber
Patrimonio netto: 208 613 $ in data 30/06/2026
Patrimonio netto: 208 613 $ in data 30/06/2026
Dr. Frank T.
Weber, MD, is a CEO, Executive Director & Chief Medical Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Zambon Biotech SA. Dr. Weber was previously employed as a Chief Medical & Development Officer by Spexis Ltd., a Senior Vice President-European Medical Division by InterMune International AG, a Medical Director by MedNet GmbH, a Chief Medical Officer by Merck KGaA, and a Chief Medical Officer by Merck Serono SA. He received his doctorate degree from Universität zu Köln.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2026 | 168.950 ( 0,57% ) | 208 613 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Amministratore Delegato | 14/08/2023 |
| Società | Posizione | Fine |
|---|---|---|
| MERCK KGAA | Direttore Tecnico/Scientifico/R&S | - |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Corporate Officer/Principal | - |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Direttore Tecnico/Scientifico/R&S | - |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Corporate Officer/Principal | - |
| SPEXIS AG | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität zu Köln
Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Distribution Services |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale